Ensayos clínicos

8.676 ensayos encontrados

Activo, no reclutaFase 3ClinicalTrials.gov

ZEUS - Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Participants With Established Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease and Systemic Inflammation

INTERVENTIONALInicio: 30 de ago de 2021ID: NCT05021835

CompletadoFase 3ClinicalTrials.gov

Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes

INTERVENTIONALInicio: 23 de sept de 2013ID: NCT01850615

CompletadoFase 3ClinicalTrials.gov

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate to Severe Atopic Dermatitis BREEZE-AD7

INTERVENTIONALInicio: 16 de nov de 2018ID: NCT03733301

CompletadoFase 3ClinicalTrials.gov

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus

INTERVENTIONALInicio: 26 de jul de 2015ID: NCT02420262

Activo, no reclutaClinicalTrials.gov

Real World Utilization of Upadacitinib in Adult and Adolescent Patients Living With Moderate to Severe Atopic Dermatitis (AD-VISE)

OBSERVATIONALInicio: 17 de nov de 2021ID: NCT05081557

CompletadoClinicalTrials.gov

Is the Placental Transfusion Volume Influenced by the Position of the New Born at Birth?

INTERVENTIONALInicio: 1 de ago de 2011ID: NCT01497353

CompletadoFase 3ClinicalTrials.gov

A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

INTERVENTIONALInicio: 2 de mar de 2021ID: NCT04740931

Activo, no reclutaFase 2ClinicalTrials.gov

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of JNJ-95475939 for the Treatment of Participants With Moderate to Severe AD

INTERVENTIONALInicio: 26 de feb de 2025ID: NCT06881251

TerminadoFase 2ClinicalTrials.gov

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3375880 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis: The ADmIRe Study

INTERVENTIONALInicio: 12 de feb de 2019ID: NCT03831191

TerminadoFase 2ClinicalTrials.gov

A Randomised, Double Blind, Placebo-controlled, Multiple Dose, Phase 2b, 24 Week Trial Followed by an Open Label Extension of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics

INTERVENTIONALInicio: 1 de ago de 2012ID: NCT01636817

TerminadoFase 3ClinicalTrials.gov

A Multi-center, Double-blinded and Open-label Extension Study to Evaluate the Efficacy and Safety of Ligelizumab as Retreatment, Self-administered Therapy and Monotherapy in Chronic Spontaneous Urticaria Patients Who Completed Studies CQGE031C2302, CQGE031C2303, CQGE031C2202 or CQGE031C1301

INTERVENTIONALInicio: 8 de abr de 2020ID: NCT04210843

CompletadoFase 3ClinicalTrials.gov

A Trial Comparing the Effect and Safety of Insulin Degludec Versus Insulin Detemir, Both in Combination With Insulin Aspart, in the Treatment of Pregnant Women With Type 1 Diabetes

INTERVENTIONALInicio: 22 de nov de 2017ID: NCT03377699

Activo, no reclutaClinicalTrials.gov

Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients Whose Disease is Not Adequately Controlled With Topical Prescription Therapies or When Those Therapies Are Not Medically Advisable

OBSERVATIONALInicio: 5 de abr de 2019ID: NCT03849716

ReclutandoClinicalTrials.gov

Assessing the Usefulness of Functional Electrical Stimulation Program on Tibial Nerve for Rehabilitation of Chronic Stroke Patients

INTERVENTIONALInicio: 21 de mar de 2022ID: NCT05240716

CompletadoFase 3ClinicalTrials.gov

A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Patients With Neovascular Age-Related Macular Degeneration (AVONELLE-X)

INTERVENTIONALInicio: 19 de abr de 2021ID: NCT04777201

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallelgroup, 3-arm, Multinational, Multicenter Study to Evaluate the Efficacy and Safety of Amlitelimab Monotherapy by Subcutaneous Injection in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

INTERVENTIONALInicio: 21 de dic de 2023ID: NCT06181435

CompletadoClinicalTrials.gov

Long-term Safety Follow-up of REMICADE (RESULTS)

OBSERVATIONALInicio: 1 de feb de 2002ID: NCT00261976

ReclutandoFase 2ClinicalTrials.gov

A Randomized, Double-blind, Parallel Group, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety and Tolerability of Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

INTERVENTIONALInicio: 9 de oct de 2024ID: NCT06470048

TerminadoFase 2ClinicalTrials.gov

Long-Term Extension Study (AtDvance) to Evaluate the Safety and Efficacy of GSK1070806 in Participants With Moderate to Severe Atopic Dermatitis.

INTERVENTIONALInicio: 5 de jun de 2024ID: NCT06447506

ReclutandoFase 3ClinicalTrials.gov

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis

INTERVENTIONALInicio: 3 de dic de 2025ID: NCT06979453